Lincomycin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antibiotic that acts by inhibiting the intracellular protein synthesis of bacteria, see also clindamycin.

Half-lifeThis section has been translated automatically.

4,6 h

Spectrum of actionThis section has been translated automatically.

Actinomyces spp., Bacteroides fragilis, Corynebacterium diphtheriae, Coxiella burnetii, Mycoplasma pneumoniae, Staph. aureus, coagulase-negative staphylococci, Streptococcus spp.

Dosage and method of useThis section has been translated automatically.

  • 3-4 times 500 mg/day p.o. or 2-4 times 600 mg/day i.m. or i.v.
  • Children > 1 month: 30-60 mg/kg bw/day divided into 3 doses p.o. or 10 mg/kg bw/day i.v. divided into 2-3 doses.

PreparationsThis section has been translated automatically.

Albiotic

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer